Canada signs deals with Pfizer, Moderna to get doses of COVID-19 vaccines
OTTAWA -- Canada is signing deals with pharmaceutical giant Pfizer and U.S.-based biotech firm Moderna to procure millions of doses of their experimental COVID-19 vaccines.
Procurement Minister Anita Anand is announcing the deals this morning in Toronto, which will see Canada get access to the vaccines if they prove to be both safe and effective.
Both companies began Phase 3 clinical trials of their vaccine candidates in the last week, large-scale tests to determine how well the vaccines work.
Earlier in July both Pfizer and Moderna reported positive results from smaller trials.
The Phase 3 trials will both test the vaccines on 30,000 people, and results are expected in the fall.
Canada's chief public health officer Dr. Theresa Tam warned Tuesday about expecting a vaccine to provide a quick end to the pandemic, saying they provide hope but likely no silver bullet for the novel coronavirus.
The Canadian Press
- Canada signs deals with two suppliers for potential COVID-19 vaccines
- Canada signs deal with Novovax to get 76 million doses of COVID-19 vaccine
- Canadian company urges human trials after COVID-19 vaccine results in mice
- Public health officials urge Canadians to limit contacts again as COVID-19 cases rise
- Feds pledge $440 million to join international vaccine program
- Mississauga grandfather celebrating big lotto win
- A McDonald's location inside a Walmart in Mississauga has temporarily closed down due to a COVID-19 case
- Police searching for suspect following sexual assault at GO station in Mississauga
- Ontario reports 435 new COVID-19 cases, no new deaths
- Peel District schools in Mississauga with reported cases of COVID-19 – September 25